Birchview Capital, Lp Portfolio Stock Holdings
According to the SEC 13F filed on August 14, 2026, Birchview Capital, Lp disclosed 64 stock positions valued at approximately $213.83M as of quarter-end June 30, 2026. The largest holdings include KLA CORPORATION, BRISTOL-MYERS SQUIBB CO, and LAM RESEARCH CORPORATION.
- Report Period
- June 30, 2026
- No. of Stocks
- 64
- Portfolio Value
- $213.83M
Holdings by Sector
Birchview Capital, Lp Portfolio Holdings in Q2 2026
| Company | Symbol | Sector | Portfolio % | Shares | Change (Shares) | Change % | Value |
|---|---|---|---|---|---|---|---|
| KLA CORPORATION | KLAC | Technology | 25.18% | 178,471 | +158,588 | +797.61% | $53,846,485 |
| BRISTOL-MYERS SQUIBB CO | BMY | Healthcare | 8.01% | 297,243 | -9,025 | -2.95% | $17,127,142 |
| LAM RESEARCH CORPORATION | LRCX | Other | 7.09% | 35,000 | -1,000 | -2.78% | $15,166,550 |
| INTELLIA THERAPEUTICS INC | NTLA | Healthcare | 3.17% | 385,900 | -60,000 | -13.46% | $6,780,968 |
| SOLID BIOSCIENCES INC | SLDB | Healthcare | 3.11% | 666,196 | +40,216 | +6.42% | $6,655,298 |
| BIODESIX INC | BDSX | Healthcare | 3.02% | 286,804 | - | - | $6,467,429 |
| STOKE THERAPEUTICS INC | STOK | Healthcare | 2.73% | 178,110 | -31,890 | -15.19% | $5,827,759 |
| OVINTIV INC | OVV | Energy | 2.65% | 107,500 | - | - | $5,659,875 |
| CORCEPT THERAPEUTICS INC | CORT | Healthcare | 2.33% | 57,200 | +10,000 | +21.19% | $4,973,540 |
| NEUROCRINE BIOSCIENCES INC | NBIX | Healthcare | 2.14% | 27,190 | - | - | $4,582,467 |
| ACADIA PHARMACEUTICALS INC | ACAD | Healthcare | 2.02% | 171,000 | - | - | $4,326,300 |
| PROTAGONIST THERAPEUTICS INC | PTGX | Healthcare | 2.01% | 35,018 | +18 | +0.05% | $4,292,506 |
| COMPASS THERAPEUTICS INC | CMPX | Healthcare | 1.72% | 1,675,000 | +209,133 | +14.27% | $3,668,250 |
| RELMADA THERAPEUTICS INC | RLMD | Healthcare | 1.32% | 408,100 | -1,287 | -0.31% | $2,824,052 |
| ALKERMES PLC | ALKS | Healthcare | 1.23% | 50,000 | - | - | $2,619,750 |
| HALOZYME THERAPEUTICS INC | HALO | Healthcare | 1.22% | 33,251 | +23,151 | +229.22% | $2,602,556 |
| CELLDEX THERAPEUTICS INC | CLDX | Healthcare | 1.22% | 69,900 | -195 | -0.28% | $2,600,979 |
| CYTOKINETICS INC | CYTK | Healthcare | 1.20% | 30,000 | - | - | $2,555,700 |
| OLEMA PHARMACEUTICALS INC | OLMA | Healthcare | 1.16% | 199,000 | -20,000 | -9.13% | $2,489,490 |
| VERA THERAPEUTICS INC | VERA | Healthcare | 1.16% | 57,758 | +13,758 | +31.27% | $2,478,396 |
| UNITED THERAPEUTICS CORP | UTHR | Healthcare | 1.14% | 4,506 | +6 | +0.13% | $2,441,486 |
| ZENAS BIOPHARMA INC | ZBIO | Other | 1.11% | 93,601 | +23,601 | +33.72% | $2,375,593 |
| UNIQURE NV | QURE | Other | 1.09% | 50,697 | -50,000 | -49.65% | $2,335,104 |
| PACIFIC BIOSCIENCES OF CALIFORNIA INC | PACB | Healthcare | 1.06% | 1,350,000 | -150,000 | -10.00% | $2,268,000 |
| ABIVAX SA | ABVX | Healthcare | 1.06% | 17,000 | +17,000 | +100.00% | $2,265,420 |
| VIR BIOTECHNOLOGY INC | VIR | Healthcare | 1.05% | 220,000 | +220,000 | +100.00% | $2,241,800 |
| BIOGEN INC | BIIB | Healthcare | 0.91% | 9,000 | +4,000 | +80.00% | $1,944,540 |
| EQT CORPORATION | EQT | Energy | 0.86% | 34,619 | - | - | $1,840,692 |
| TRAVERE THERAPEUTICS INC | TVTX | Healthcare | 0.77% | 29,000 | -200 | -0.68% | $1,647,490 |
| AXSOME THERAPEUTICS INC | AXSM | Healthcare | 0.69% | 6,000 | - | - | $1,468,620 |
Showing 30 of 64 holdings in the latest reporting period.